Metagenomi Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold MGX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$1015425
Total value held
Buying
4 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Wells Fargo & Company/Mn | $451614 | 379508 | +177370 | +87.75% |
| 2 | Blackrock, Inc. | $306581 | 257631 | +27497 | +11.95% |
| 3 | State Street Corp | $142622 | 119850 | -577 | -0.48% |
| 4 | Northern Trust Corp | $82036 | 68938 | -6234 | -8.29% |
| 5 | Ubs Group Ag | $18794 | 15793 | +15793 | NEW BUY |
| 6 | Morgan Stanley | $6309 | 5302 | -22264 | -80.77% |
| 7 | Us Bancorp \De\ | $5355 | 4500 | — | Held |
| 8 | Jpmorgan Chase & Co | $1915 | 1596 | — | Held |
| 9 | Barclays Plc | $199 | 167 | +167 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.